Intravenous pamidronate for refractory lymphedema

Beigi, A.A. and Sadeghi, A.M. and Masoudpour, H. and Shirazinejad, S. and Mottaghi, P. (2011) Intravenous pamidronate for refractory lymphedema. Iranian Red Crescent Medical Journal, 13 (4). pp. 263-266.

Full text not available from this repository.
Official URL:


Background: Based on beneficial reports of pamidronate use for reflex sympathetic dystrophy in reduction of pain and swelling, this drug can be studied as a novel treatment for refractory lymphedema. This study aims to determine the effectiveness of pamidronate on lymphedema and its possible side effects. Methods: Twelve cases of lower limb refractory lymphedema were enrolled. They received intravenous pamidronate monthly for 3 consecutive months and were followed by measuring any discomfort with visual analog scale (VAS) and physician global assessment, based on objective signs of limb volume and circumference. Results: The limb volume, circumference, and satisfaction of the patients improved significantly. Conclusion: Pamidronate when is added to conservative treatments may reduce lymphedema and improve the patient's comfort. © Iranian Red Crescent Medical Journal.

Item Type: Article
Additional Information: cited By 2
Uncontrolled Keywords: pamidronic acid, adult; anthropometric parameters; article; clinical article; drug efficacy; female; human; limb circumference; limb volume; lymphedema; male; myalgia; patient satisfaction; visual analog scale
Subjects: Medicine
Divisions: Faculty of Medicine > Clinical Sciences > Department of Surgery
Depositing User: editor . 2
Date Deposited: 27 Feb 2017 07:57
Last Modified: 11 Mar 2017 13:24

Actions (login required)

View Item View Item